We invite you to take part in the XIX Annual International Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), which will be held May 30 - June 4, 2014 in Montreal, Canada. Congress brings together experts in health economics, health managers, researchers, representatives of the pharmaceutical business. About 3000 participants are planning to visit upcoming Congress.
Topics of plenary meetings of Congress
- Using a large database - where are we now and what will happen in the future?
- What are the advantages and disadvantages of using observational data as a basis of decision making in health care? How does this affect randomized controlled studies?
- To what extent should the indicators, calculated by pharmacoeconomic study, used in decision making in health care?
In addition to of plenary meetings at the Congress held sectional meetings on all major clinical specialties, organizations and health economics, quality of life research and more.
Congress participants can take part in one of the schools on pharmacoeconomics in English on the following topics:
- Introduction to Pharmacoeconomics
- Bayesian Analysis - Overview and Applications
- Introduction to Database Analysis of Observational Studies of Treatment Effects
- Introduction to Modeling Methods
- Introduction to Patient-Reported Outcomes
- Introduction to Budget Impact Analysis: A 6-Step Approach
- Elements of Pharmaceutical/Biotech Pricing I - Introduction
- Meta-Analysis and Systematic Reviews in CER
- Utility Measures
- Modeling: Design and Structure of a Model
- Case Studies in Pharmaceutical / Biotech Pricing II - Advanced
- Cost-Effectiveness Analysis Alongside Clinical Trials
- Discrete Event Simulation for Economic Analyses - Concepts
- Statistical Methods in Economic Evaluations
- Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products,
- Advanced Decision Modeling for Health Economic Evaluations,
- Applications in Using Large Databases,
- Patient-Reported Outcomes - Item Response Theory,
- Use of Instrumental Variables in Observational Studies of Treatment Effects,
- Introduction to Conjoint Analysis,
- NEW! Budget Impact Analysis: Applications and Design Issues,
- Discrete Event Simulation for Economic Analyses - Applications,
- Network Meta-Analysis for Indirect Treatment Comparison,
- Use of Propensity Scores in Observational Studies of Treatment Effects,
- Applying Mixed Methods to Establish the Content Validity of PRO, ClinRO & ObsRO Assessments,
- Agent-Based Modeling for Economic Evaluations
- Value of Information and Probabilistic Analyses.
Also planned for the traditional Russian Forum and Discussion Club to discuss topical issues of Russian health care.
Contact: Director of Economics RSPOR Holownya Malvina.
Internet site of the Congress: